Neuromodulation & Cardiovascular Medical Device Products

http://www.sorin.com/

Last activity: 04.08.2026

Active

Categories: MedTechTechnology

LivaNova is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world.

Youtube

Mentions

Overview

Employees

5001-10000

Founded date

2004

Mentions in press and media 20

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Aug 4, 2026	Agentic enterprise AI startup Kily raises Rs 30 crore from Sorin, Razorpay, Wyser Capital	Agentic enterprise AI startup Kily has raised Rs 30 crore in a funding round led by Sorin Investments, with participation from fintech giant Razorpay and Wyser Capital. Advertisment Founded in 2025 by Sankalp Mehrotra, Anurag Singh and Shar...
May 30, 2024	Sanjay Nayar-led Sorin Investments closes maiden fund at $162 mn	Sanjay Nayar Sorin Investments, a tech-focused investment firm co-founded by private equity veteran Sanjay Nayar and Angad Banga of Hong Kong-based Caravel group, has made the final close of its maiden fund with a corpus of Rs 1,350 crore (...
Jul 18, 2022	Sanjay Nayar’s tech fund Sorin raises $100 mn in first close	Sanjay Nayar’s tech fund Sorin raises $100 mn in first close Premium Sanjay Nayar, co-founder of Sorin Investments. mint 3 min read . Updated: 18 Jul 2022, 12:47 AM IST Swaraj Singh Dhanjal The fund will invest $2-10 million and will look t...
Jul 18, 2022	Sanjay Nayar’s Sorin Investments Raises $100 Mn In First Close Of Debut Fund	Sorin will look to raise as much as around $130 Mn in the fund, with a greenshoe option of $30 Mn It will write a dozen cheques worth between $2 Mn and $10 Mn for startups in Series A to Series C The fund will invest in startups from fintec...
Oct 22, 2014	Sorin drops $20m on stake in Respicardia	Sorin Group (BIT:SRN) said it invested $20 million in a minority stake and controlling option in Minnetonka, Minn.-based Respicardia, which is developing implantable devices to treat central sleep apnea. Milan, Italy-based Sorin also said i...
Feb 10, 2014	U Minnesota spinout raises $860K for resorbable embolization material	“That’s the way to go, and everyone wants a drug-loaded embolization material,” he said. The company seeks to use the solution as an interventional radiology treatment for men’s prostates, to shrink uterine fibroid tumors and in coordinatio...
Dec 2, 2013	Sorin lands CE Mark for MRI-compatible pacemaker	Sorin Group (BIT:SRN) said it won CE Mark approval in the European Union for its Kora 100 DR and SR pacemakers. Milan-based Sorin said the devices feature an automatic MRI mode when implanted with the Sorin Beflex pacing lead. This allows t...
Nov 22, 2013	Sorin wins CE Mark for stentless heart valve	Sorin Group (BIT:SRN) said it won CE Mark approval in the European Union for its Solo Smart heart valve, designed to replace the aortic valve without leaving a stent in place. Milan-based Sorin said the Solo Smart device is the next iterati...
Jul 30, 2013	Sorin puts 2012 earthquake behind with 92% Q2 profit growth	Sorin Group (BIT:SRN) said it’s finally put the impact of a devastating earthquake behind it, reporting surging profit growth and a return to normal operations for the Italian plant hit by the temblor. The Italian medical device company pos...
Jul 10, 2012	Cardiosolutions Receives $8M Minority Investment from Sorin	Cardiosolutions, Inc., a West Bridgewater, MA-based developer of a percutaneous system to treat patients with moderate to severe mitral valve regurgitation, has received an $8m minority investment. The funding was provided by Sorin Group (R...
May 24, 2012	Sorin aims to become a player in the U.S. medical device market	Sorin Group (BIT:SRN) is an established leader in the cardiac rhythm management space, but in the U.S. it’s a back-bencher compared with more established competitors like Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX) and St. Jude Medic...
May 11, 2012	Biotronik touts FDA approval for next-gen heart devices at HRS 2012 \| Regulatory Roundup	Biotronik wins FDA aproval for next-gen heart failure devices Biotronik landed FDA approval for its next-generation series of implantable heart devices, announcing the win at this year’s Heart Rhythm Society conference in Boston yesterday. ...
Feb 13, 2012	Sorin’s 2011 profits rise despite flat sales \| Earnings Roundup	Sorin Group (BIT:SRN) managed to raise its bottom line despite flat sales for 2011 by raising its gross margin via restructuring, posting a profit increase of 48.3% for the year. The Milanese cardiovascular device maker reported profits of ...
Feb 7, 2012	Boston Scientific touts CE Mark for spinal stimulator lead \| Regulatory Roundup	Boston Scientific (NYSE:BSX) landed CE Mark approval in the European Union for its Infinion 16 percutaneous lead, designed for use with the company’s Precision Plus spinal cord stimulator system. BSX’s spinal cord stimulator leads are desig...
Oct 19, 2011	Diabetes: Remote monitoring diabetes management system wins FDA clearance \| Regulatory Roundup	ALR Technologies Inc. (OTC:ALRT) landed FDA clearance for its Health-e-Connect System for diabetes management programs. The web-based patient management platform allows doctors to remote monitor diabetic patients, a system that could result...
Feb 24, 2011	Sorin Group and Versant Ventures Join MD Start as Shareholders	MD Start, a Lausanne, Switzerland-based venture capital- and industry-backed medical device technology incubator, has added medical device company Sorin Group and healthcare venture capital firm Versant Ventures as shareholders. Founded by ...
Oct 4, 2010	Sorin subsidiary ELA Medical looks to settle federal beef for $10 million	Italian medical device maker Sorin Group said it reached a tentative, $10 million settlement with the U.S. Dept. of Justice in case accusing its ELA Medical subsidiary of running an illegal kickbacks scheme. The Justice Dept. opened an inve...
	Sorin Investments closes maiden early-stage VC fund at Rs 1,350 Cr	Sorin Investments, an early-stage venture capital firm co-founded by former KKR India head Sanjay Nayar has announced the final close of its maiden fund at Rs 1,350 crore. Sorin aims to invest at the Series A and B stages of funding cutting...
	U Minnesota spinout raises $860K for resorbable embolization material	EmboMedics, a Maple Grove, Minn.-based medical device company, has raised $860,000 in equity, according to a regulatory filing made with the SEC. The Series A funding will go mainly toward research and development of its resorbable emboliza...

Reviews 0

FAQ about Neuromodulation & Cardiovascular Medical Device Products

When was Neuromodulation & Cardiovascular Medical Device Products founded?

Neuromodulation & Cardiovascular Medical Device Products was founded in 2004.

What has the press written about Neuromodulation & Cardiovascular Medical Device Products?

Parsers VC has collected 20 articles mentioning Neuromodulation & Cardiovascular Medical Device Products, among them “Agentic enterprise AI startup Kily raises Rs 30 crore from Sorin, Razorpay, Wyser Capital” (Aug 4, 2026) and “Sanjay Nayar-led Sorin Investments closes maiden fund at $162 mn” (May 30, 2024).

Is Neuromodulation & Cardiovascular Medical Device Products still active?

Yes, Neuromodulation & Cardiovascular Medical Device Products is active; its latest activity on Parsers VC dates from Aug 4, 2026.